Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
AssigneeAlkahest, Inc.
InventorsSteven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
Claims13
A method of treating a subject diagnosed with a cognitive impairment, the method comprising, administering to the subject an effective amount of young plasma using a Pulse Dosed dosing regimen, wherein the Pulse Dosed dosing regimen comprises at least 3 to 14 consecutive days of administration.
A method of treating a subject diagnosed with a cognitive impairment, the method comprising, administering to the subject an effective amount of a Human Albumin Solution using a Pulse Dosed dosing regimen, wherein the Pulse Dosed dosing regimen comprises at least 3 to 14 consecutive days of administration, wherein the Human Albumin Solution comprises an albumin content of at least 95%, with no more than 5% globulins.
Dependencies are inferred from the claim text.